Oncology Institute (TOI) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 955.6%.
| ASSET | % RETURN |
|---|---|
Oncology Institute (TOI) | 955.56% |
Janover Inc Common Stock (JNVR) | 953.82% |
Regencell Bioscience (RGC) | 479.13% |
Dominari (DOMH) | 388.48% |
Global Interactive Technologies (GITS) | 385.48% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 339.83% |
Nutex Health (NUTX) | 338.68% |
Abits (ABTS) | 287.46% |
Upexi (UPXI) | 275.56% |
CervoMed (CRVO) | 266.67% |
Yoshiharu Global (YOSH) | 258.18% |
Oriental Culture Holding (OCG) | 231.93% |
TMC the metals (TMC) | 223.68% |
Junee Limited Ordinary Shares (JUNE) | 210.86% |
ThredUp (TDUP) | 186.11% |
DBV Technologies (DBVT) | 170.52% |
Neuronetics (STIM) | 156.97% |
Rapid Micro Biosystems (RPID) | 154.95% |
Vasta Platform (VSTA) | 143.5% |
Chimerix (CMRX) | 143.3% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 138.69% |
Hertz Global (HTZ) | 133.15% |
Curiositystream (CURI) | 132.45% |
908 Devices (MASS) | 132.44% |
VivoPower International (VVPR) | 124.44% |
